Tardigrades are tiny animals that survive being dried out completely. This tardigrade protein cold chain research borrows one of their proteins to keep medicines stable without refrigeration. The work is in the lab stage, not clinic ready, but the results…
KuCoin Chinese scientists launch open-source RNA model structRFM, published in Nature Author and source: AIBase A research team from the University of Science and Technology of China has recently achieved a major breakthrough at the intersection of life sciences and…
Analyzing a massive collection of data from 150,000 patient tumor samples, researchers have identified T cell receptors against cancer that are shared across multiple patients. Cross patient immune repertoire mining reveals novel cancer receptor families Analyzing a massive collection of data…
Meeting the shift to precision editing IDT has also released Alt-R CRISPR-Cas9 sgRNA XT to maximize editing performance across both base editing and Cas9-mediated workflows using mRNA. Together with the new IDT bioinformatics tool for pegRNA design, these solutions give…
Three-dimensional cancer organoids closely mimic parental tumor features, making them valuable for cancer research, drug screening, and personalized medicine. However, traditional organoid cultures lack key tumor microenvironment (TME) components—cancer-associated fibroblasts, immune cells, vascular networks, and dynamic physicochemical cues—limiting…
Wollongong-based online news outlet covering Australia and beyond. If you have anything newsworthy - a story, video or picture to share with us, please email us. Three‐dimensional cancer organoids cultured in vitro closely recapitulate the phenotypic and genetic features of…
Research examines a self-reinforcing resistance niche created by extracellular chromatin released during CAR T-cell killing and its reversal by DNase I Presentation selected for ASH scientific session focused on overcoming resistance in CAR T-cell therapy The research will be featured…
Nasdaq Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting Nov 4, 2026 9:50am EST Initial Phase 1/2 data highlight the potential of Moderna's multiplexed mRNA approach in relapsed or refractory multiple myeloma CAMBRIDGE, MA / ACCESS Newswire / November…
Wave Life Sciences, Inc. (WVE) Research Day: RNA Medicines Platform and Pipeline Innovation November 4, 2026 9:30 AM EST Kate Rausch - Vic President of Corporate Affairs & Investor RelationsPaul Bolno - President, CEO & DirectorErik Ingelsson - Chief Scientific OfficerChandra Vargeese - Chief Technology OfficerChristopher Wright - Chief Medical…
A new Frontiers editorial argues that mechanical forces in tumors regulate invasion, immune surveillance, and treatment response, and that the field is shifting from cataloguing mechanosensitive molecules to identifying where and when those cues are decisive.
mRNA platforms, boosters, monoclonals, and immune‑system science.
An article joins this feed when it matches these terms. Each one is also a search of its own.